XML 31 R19.htm IDEA: XBRL DOCUMENT v3.23.3
SHAREHOLDERS' EQUITY
 9 Months Ended
Sep. 30, 2023
SHAREHOLDERS' EQUITY
9. SHAREHOLDERS’ EQUITY
At-the-Market
Offering Program
On February 25, 2022, we entered into an amended and restated sales agreement with Robert W. Baird & Co. Inc. (“Baird”) and Goldman Sachs & Co. LLC (“GS”), which enables the Company to issue and sell shares of Common stock in one or more negotiated transactions or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), for a maximum aggregate offering amount of up
to $300,000 (
the “ATM Program”). The offer and sale of our Common stock pursuant to the ATM Program has been registered under the Securities Act pursuant to our automatically effective shelf registration statement on Form
S-3
(File
No. 333-260758).
During
the nine months ended September 30, 2023, we issued and sold 45,000 shares of Common stock under the ATM Program for net proceeds of $15,179. Direct costs of $375 incurred in connection with the offering were charged against the proceeds from the sale of Common stock and reflected as a reduction of
paid-in
capital. At September 30, 2023, $284,745 remained available for sale under the ATM Program.
On November 3, 2023, we entered into a second amended and restated sales agreement with Baird, which removed GS as a sales agent under the ATM Program.
Common Stock Dividends
We paid cash dividends of $2.45, $2.20, $7.35, and $6.35 per share on both Common and Class B common stock during the quarters and nine months ended September 30, 2023 and 2022, respectively.
Restricted Stock
During the quarter and nine months ended September 30, 2023,
a total of
1,033 shares of Common and Class B common stock with an aggregate fair market value of $362, and
a total of
7,080 shares of Common and Class B common stock with an aggregate fair market value of $2,026, respectively, were withheld as payment in lieu of cash to satisfy tax withholding obligations in connection with the vesting of restricted stock. These shares were retired upon delivery. During the quarter and nine months ended September 30, 2022,
a total of
879 shares of Class B common stock with an aggregate fair market value of $252, and
a total of
9,060 shares of Class B common stock with an aggregate fair market value of $2,431, respectively, were withheld as payment in lieu of cash to satisfy tax withholding obligations in connection with the vesting of restricted stock. These shares were retired upon delivery.
Exercise of Stock Options
Cash received from Common stock issued as a result of stock options exercised during the quarters and nine months ended September 30, 2023 and 2022, was
$5,983, $7,929, $18,677, and $15,151, respectively.
During the quarter and nine months ended September 30, 2023, a total of
295
shares of Common stock with an aggregate fair market value of
$106
, and a total of 17,687 shares of Common stock with an aggregate fair market value of 
$
5,489
, respectively, were withheld as payment in lieu of cash for stock option exercises. These shares were retired upon delivery. During both the quarter and nine months ended September 30, 2022, a total of
 
1,053
shares of Common stock with an aggregate fair market value of $298 were withheld as payment in lieu of cash for stock option exercises. These shares were retired upon delivery.
Employee Stock Purchase Plan
During the quarters ended September 30, 2023 and 2022, we received net proceeds of $563 and $478, respectively, for shares of our Common stock purchased under our employee stock purchase plan. During the nine months ended September 30, 2023 and 2022, we received net proceeds of $1,696 and $1,484, respectively, for shares of our Common stock purchased under our employee stock purchase
plan.